Clinical trial
Hydrocortisone Versus Hydrocortisone Plus Fludrocortisone for the Treatment of…
NCT00368381 · CAMC Health System, Other · Withdrawn
Key facts
| NCT number | NCT00368381 |
|---|---|
| Title | Hydrocortisone Versus Hydrocortisone Plus Fludrocortisone for the Treatment of Adrenal Insufficiency in Severe Sepsis |
| Official title | A Blinded, Placebo Controlled Trial of Hydrocortisone Versus Hydrocortisone Plus Fludrocortisone for the Treatment of Adrenal Insufficiency in Severe Sepsis |
| Lead sponsor | CAMC Health System, Other |
| Status | Withdrawn |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Sepsis, Adrenal Insufficiency |
| Intervention type | Drug |
| Interventions | Hydrocortisone |
| Enrollment | 0 |
| Start date | Sep 1, 2006 |
| Primary completion | Jul 1, 2009 |
| Completion | Sep 1, 2009 |
| First posted | Aug 24, 2006 |
| Last update posted | Feb 13, 2012 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: